Ariadne and Aureus Pharma to Collaborate for Support of Knowledge Management Solutions
News May 26, 2010
Ariadne and Aureus are joining forces with the goal to deliver knowledge management solutions for the life sciences industry, and announce that Ariadne will distribute Aureus’ offerings in the US.
The two companies will initiate a collaboration to explore together further synergies between their respective knowledge management solutions and more particularly the interfaces between the protein pathway space and medicinal chemistry. Such interfaces will help customers to better understand mechanisms of actions between therapeutic proteins, protein pathways and small molecules and provide new insights in the disease biology area.
“This engagement highlights the ongoing evolution of Ariadne,” says Ilya Mazo, Ph.D. and CEO, “by partnering with best-in-class providers of knowledge management solutions. We can provide solutions that enable customers to take advantage of both Ariadne and Aureus’ products where it makes sense in their organization, workflow and informatics infrastructure. We believe that this collaboration will make it possible to offer the highest level of interoperability between our companies, along with improved solutions for knowledge management.”
“The partnership between Aureus and Ariadne will enable to support synergies in discovery and development workflows as used across multiple departments and scientific disciplines in the Life Science Industry,” says Jason Theodosiou, CEO of Aureus Pharma. “Both companies are innovative and have created solutions that organize high quality data from various sources to better identify, create, distribute, and enable knowledge integration within an organization.”
The collaboration will establish confidence between researchers in disease biology and medicinal chemistry that the technologies they use and deploy in their specific environments provide continuity in the pipeline discovery process, align common goals in knowledge management and increase scientific comprehension between these two groups.
Financial terms were not disclosed.
Stem Cells in Menstrual Blood Could Help Diagnose EndometriosisNews
The Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately 176 million women globally.READ MORE
SMi’s 5th Annual Molecular Diagnostics Conference 2018 Agenda ReleasedNews
SMi proudly presents its 5th annual conference on Molecular Diagnostics, taking place at the Holiday Inn Kensington Forum, London, UK on 9th and 10th July 2018, with a half-day post-conference workshops on 11th July 2018.READ MORE
Pap Test Fluids Used to Test for Endometrial & Ovarian CancersNews
Cervical fluid samples gathered during routine Papanicolaou (Pap) tests are the basis of a new screening test for endometrial and ovarian cancers developed by researchers at the Johns Hopkins Kimmel Cancer Center.